Chen‐Yuan Chiang

5 ta ish

International Union Against Tuberculosis and Lung Disease

1. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

   Shama D. Ahuja, David Ashkin, Monika Avendano +70

   Sharh maqolaOAOchiq kirish20129 iqtibos

   ABIABI:AkademIndex/2026.other.027993

2. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   Andrew Nunn, Patrick Phillips, Sarah Meredith +16

   MaqolaOAOchiq kirish20196 iqtibos

   ABIABI:AkademIndex/2026.other.006848

3. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

   Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

   Sharh maqolaOAOchiq kirish20144 iqtibos

   ABIABI:AkademIndex/2026.other.034193

4. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

   Andrew Nunn, I. D. Rusen, Armand Van Deun +6

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.364687

5. Xpert^® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

   Arnaud Trébucq, Donald A. Enarson, Chen‐Yuan Chiang +9

   Maqola20112 iqtibos

   ABIABI:AkademIndex/2026.other.504209